Alexandra Kropotova Insider Trades & Stock Holdings

CHIEF MEDICAL OFFICER · SAB Biotherapeutics, Inc. · Latest filing Jun 25, 2026

Alexandra Kropotova, CHIEF MEDICAL OFFICER at SAB Biotherapeutics, Inc. has 1 Form 4 trade on file since Jun 25, 2026. Latest filing: disposed of 988 shares of $SABS on Jun 25, 2026.

Trades on file

1

Open-market bought

$0

Open-market sold

$0

Net open-market

$0

Latest filing

Jun 25, 2026

All insider trades by Alexandra Kropotova

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 25, 2026	$SABS	Sell (Tax withholding)	988	—	—			+1.3%	-11.1%		CHIEF MEDICAL OFFICER		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Alexandra Kropotova traded

• $SABS

Frequently asked questions

What was Alexandra Kropotova's latest insider trade?

disposed of 988 shares of $SABS on Jun 25, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.